Disorders of sex development (DSDs): An update

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1503-1509

  Ostrer, Harry ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; TRANSCRIPTION FACTOR SOX9;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DISORDER OF SEX DEVELOPMENT; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GONAD DEVELOPMENT; HTES GENE; HUMAN; KARYOTYPE 46,XY; MAP3K1 GENE; MAP3K4 GENE; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; NR5A1 GENE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SOX9 GENE; SRY GENE;

COMPARATIVE GENOMIC HYBRIDIZATION; DISORDERS OF SEX DEVELOPMENT; FEMALE; HUMANS; MALE; MUTATION; SEXUAL DEVELOPMENT;

EID: 84899908185     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3690     Document Type: Article

References (66)

1. Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118:e488-e500.
2. Egg ers S, Sinclair A. Mammalian sex determination-insights from humans and mice. Chromosome Res. 2012;20:215-238.
3. Ono M, Harley VR. Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol. 2013;9:79-91.
4. Ostrer H. 46,XY Disorder of sex development and 46,XY complete gonadal dysgenesis. In: Pagon RA, Adam MP, Bird TD, eds. GeneReviews. Seattle, WA: University of Washington, Sea ttle. http://www.ncbi.nlm.nih.gov/books/NBK1547/. Published May 21, 2008. Updated September 15, 2009.
5. Wilson JD, Rivarola MA, Mendonca BB, et al. Advice on the management of ambiguous genitalia to a young endocrinologist from experienced clinicians. Semin Reprod Med. 2012;30:339-350.
6. Sarafoglou K, Ostrer H. Clinical review 111: familial sex reversal: a review. J Clin Endocrinol Metab. 2000;85:483-493.
7. Berta P, Hawkins JR, Sinclair AH, et al. Genetic evidence equating SRY and the testis-determining factor. Nature. 1990;348:448-450.
8. Wirth J,WagnerT, Meyer J, et al. Translocation breakpoints in three patients with campomelic dysplasia and autosomal sex reversal map more than 130 kb from SOX9. Hum Genet. 1996;97:186-193.
9. Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRYrelated gene SOX9. Cell. 1994;79:1111-1120.
10. Achermann JC, Ito M, It o M, Hindmarsh PC, Jameson JL. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet. 1999;22:125-126.
11. Hastie ND. Dominant ne gative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome-proof that a tumoursuppressor gene plays a crucial role in normal genitourinary development. Hum Mol Genet. 1992;1:293-295.
12. Barbaux S , Niaudet P, GublerMC,et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997;17: 467-470.
13. Dabovic B, Zanaria E, Bardoni B, et al. A family of rapidly evolving genes from the sex reversal critical region in Xp21.MammGenome. 1995;6:571-580.
14. Jordan BK Mohammed M Ching ST et al. Up-regulation of wnt-4 signaling and dosage-sensitive sex reversal in humans Am J Hum Genet. 2001 68 1102-1109.
15. Biason-Lauber A, K onrad D, Meyer M, DeBeaufort C, Schoenle EJ. Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. Am J Hum Genet. 2009;84:658-663.
16. Matson CK, Murphy MW, Sarver AL, Griswold MD, Bardwell VJ, Zarkower D. DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature. 2011;476:101-104.
17. Lourenço D, Brauner R, Rybczynska M, Nihoul- FékétéC, McElreavey K, Bashamboo A. Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci USA. 2011;108:1597-1602.
18. Call KM , Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms'tumor locus. Cell. 1990;60:509-520.
19. Foster JW, Dominguez-Steg lich MA, Guioli S, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature. 1994;372:525-530.
20. Gessler M, Poustka A, Cavenee W, Neve R L, Orkin SH, Bruns GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-778.
21. Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 1994;79:1111-1120.
22. Sutton E, Hughes J, White S, et al. Identification of SOX3 as an XX male sex reversal gene in mice and humans. J Clin Invest. 2011; 121:328-341.
23. Bardoni B, Zanaria E, Guioli S, et al, et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet. 1994;7:497-501.
24. Bernstein R, Koo GC, Wachtel SS. Abnormality of the X chromosome in human 46,XY female siblings with dysgenetic ovaries. Science. 1980;207:768-769.
25. Huang B, Wang S, Ning Y, Lamb AN, Bartley J. AutosomalXXsex reversal caused by duplication of SOX9. Am J Med Genet. 1999; 87:349-353.
26. Jost A, Vigier B, Prépin J, Perchellet JP. Studies on sex differentiation in mammals. Rec Prog Horm Res. 1973;29:1-41.
27. Reynaud K, Cortvrindt R, Verlinde F, De Schepper J, Bourgain C, Smitz J. Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertil Steril. 2004;81:1112-1119.
28. Refai O, Friedman A, Terry L, et al. De novo 12;17 translocation upstream of SOX9 resulting in 46,XX testicular disorder of sex development. Am J Med Genet A. 2010;152A:422-426.
29. Cox JJ, Willatt L, Homfray T, Woods CG. A SOX9 duplication and familial 46,XX developmental testicular disorder. N Engl J Med. 2011;364:91-93.
30. Benko S, Gordon CT, Mallet D, et al. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet. 2011;48:825-830.
31. Bishop CE, Whitworth DJ, Qin Y, et al. A transgenic insertion upstream of Sox9 is associated with dominant XX Sex reversal in the mouse. Nat Genet. 2000;26:490-494.
32. Vidal VP, Chaboissier MC, de Rooij DG, Schedl A. Sox9 induces testis development in XX transgenic mice. Nat Genet. 2001;28: 216-217.
33. Barrionuevo F, Bagheri-Fam S, Klattig J, et al. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biol Reprod. 2006;74:195-201.
34. Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature. 2008; 453:930-934.
35. Knower KC Kelly S Ludbrook LM et al. Failure of SOX9 regulation in46XYdisorders of sex development with SRY,SOX9and SF1 mutations PloS One. 2011 6 e17751.
36. Achermann JC, Ozisik G, Ito M, et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab. 2002;87:1829-1833.
37. Georg I, Bagheri-Fam S, Knower KC, Wieacker P, Scherer G, Harley VR. Mutations of the SRY-responsive enhancer of SOX9 are uncommon in XY gonadal dysgenesis. Sex Dev. 2010;4:321-325.
38. Oreal E, Pieau C, Mattei MG, et al. Early expression of AMH in chicken embryonic gonads precedes testicular SOX9 expression. Dev Dyn. 1998;212:522-532.
39. Moreno-Mendoza N, Harley VR, Merchant-Larios H. Differential expression ofSOX9in gonads of the sea turtle Lepidochelys olivacea at male-or female-promoting temperatures. J Exp Zool. 1999;284: 705-710.
40. Western PS, Harry JL, Graves JA, Sinclair AH. Temperature-dependent sex determination: upregulation of SOX9 expression after commitment to male development. Dev Dyn. 1999;214:171-177.
41. Pearlman A, Loke J, Le Caignec C, et al. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet. 2010;87:898-904.
42. Loke J, Ostrer H. Rapidly screening variants of uncertain significance in theMAP3K1gene for phenotypic effects. Clin Genet. 2012; 81:272-277.
43. Loke J, Pearlman A, Radi O, et al. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/-catenin signaling. Hum Mol Genet. 2014;23:1073-1083.
44. Warr N, Bogani D, Siggers P, et al. Minor abnormalities of testis development in mice lacking the gene encoding theMAPKsignalling component, MAP3K1. PLoS One. 2011;6:e19572.
45. Bogani D, Siggers P, Brixey R, et al. Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. PLoS Biol. 2009;7: e1000196.
46. Warr N, Carre GA, Siggers P, et al. Gadd45-and Map3k4 inter-actions regul ate mouse testis determination via p38 MAPK-mediated control of Sry expression. Dev Cell. 2012;23:1020-1031.
47. Gierl MS, Gruhn WH, von Seggern A, Maltry N, Niehrs C. GADD45G functions in m ale sex determination by promoting p38 signaling and Sry expression. Dev Cell. 2012;23:1032-1042.
48. Lecointre C, Pichon O, Hamel A, et al. Familial acampomelic form of campomelic dysplasia caused by a 960 kb deletion upstream of SOX9. Am J Med Genet A. 2009;149A:1183-1189.
49. Harrison SM, Campbell IM, Keays M, et al. Screening and familial characterization of copy-number variations in NR5 A1 in 46,XY disorders of sex development and premature ovarian failure. Am J Med Genet A. 2013;161:2487-2494.
50. Brandt T, Blanchard L, Desai K, et al. 46,XY disorder of sex development and dev elopmental delay associated with a novel 9q33.3 microdeletion encompassing NR5A1. Eur J Med Genet. 2013;56: 619-623.
51. Ledig S, Hiort O, Wünsch L, Wieacker P. Partial deletion ofDMRT1 causes 46,XY ovotesticular disorder of sexual development. Eur J Endocrinol. 2012;167:119-124.
52. Moalem S, Babul-Hirji R, Stavropolous DJ, et al. XX male sex reversal with genital abnormalities associ ated with a de novo SOX3 gene duplication. Am J Med Genet A. 2012;158A:1759-1764.
53. Norling A, Lindén Hirschberg A, Iwarsson E, Persson B, Wedell A, Barbaro M. Novel candidate genes for 46, XY gonadal dysgenesis identified by a customized 1 M array-CGH platform. Eur J Med Genet. 2013;56:661-668.
54. White S, Hewitt J, Turbitt E, et al. A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development. Eur J Hum Genet. 2012;20:348-351.
55. White S, Ohnesorg T, Notini A, et al. Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis. PloS One. 2011;6:e17793.
56. Wheeler DA, Srinivasan M, Egholm M, et al. The complete genome of an individual by massively parallel DNA sequencing. Nature. 2008;452:872-876.
57. Ostrer H. Changing the game with whole exome sequencing Clin Genet. 2011 80 101-103.
58. NgSB, Buckingham KJ, Lee C, et al.Exomesequencing identifies the cause of a mendelian disorder. Nat Genet. 2010;42:30-35.
59. Shendure J, Porreca GJ, Reppas NB, et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science. 2005;309: 1728-1732.
60. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437: 376-380.
61. Cooper DN, Krawczak M. The mutational spectrum of single basepair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 1990;85:55-74.
62. Arboleda VA, Lee H, S ánchez FJ, et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin Genet. 2013;83:35-43.
63. Baxter RM, Vilain E. Translational genetics for diagnosis of human disorders of sex development. Annu Rev Genomics Hum Genet. 2013;14:371-392.
64. Pierce SB, Walsh T, Chisholm KM, et al. Mutations in the DBPdeficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxi a of Perrault syndrome. Am J Hum Genet. 2010;87:282-288.
65. Pierce SB, Gersak K, Michaelson-Cohen R, et al. Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome. Am J Hum Genet. 2013;92:614-620.
66. Pierce SB, Chisholm KM, Lynch ED, et al. Mutations in mitochondrial histidyltRNAsynthetaseHARS2cause o varian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci USA. 2011;108:6543-6548.